Can newer anti-diabetic therapies delay the development of diabetic nephropathy?

Can newer anti-diabetic therapies delay the development of diabetic nephropathy?

Type 2 diabetes mellitus (T2DM) is progressive in nature and leads to hyperglycemia-associated microvascular and macrovascular complications. Diabetic nephropathy (DN) is one of the most prominent microvascular complication induced by T2DM and is characterized by albuminuria and progressive loss of...

Full description

Bibliographic Details
Main Authors: Sohail Aziz, Siti Maisharah Sheikh Ghadzi, Syed Azhar Syed Sulaiman, Nur Hafzan Md Hanafiah, Sabariah Noor Harun
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
ddp4i
diabetes progression
diabetic nephropathy
glucagon-like peptide-1 agonist
newer antidiabetics
peroxisome proliferator-activated receptors-γ
sglt-2i
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=4;spage=341;epage=351;aulast=Aziz

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=4;spage=341;epage=351;aulast=Aziz

Similar Items